WallStreetZenWallStreetZen

NASDAQ: APYX
Apyx Medical Corp Stock Forecast, Predictions & Price Target

Analyst price target for APYX

Based on 1 analyst offering 12 month price targets for Apyx Medical Corp.
Min Forecast
$5.00+237.84%
Avg Forecast
$5.00+237.84%
Max Forecast
$5.00+237.84%

Should I buy or sell APYX stock?

Based on 1 analyst offering ratings for Apyx Medical Corp.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APYX stock forecasts and price targets.

APYX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-10

1 of 1

Forecast return on equity

Is APYX forecast to generate an efficient return?
Company
N/A
Industry
-0.02%
Market
19.16%

Forecast return on assets

Is APYX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.02%

APYX revenue forecast

What is APYX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$50.1M-4.37%
Avg 2 year Forecast
$53.6M+2.41%
Avg 3 year Forecast
$58.8M+12.4%
APYX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APYX revenue growth forecast

How is APYX forecast to perform vs Medical Devices companies and vs the US market?
Company
1.72%
Industry
8.44%
Market
9.03%
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APYX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
APYX$1.48$5.00+237.84%Strong Buy
ICCM$1.19$2.95+147.90%Strong Buy
IRIX$2.96N/AN/A
SRTS$3.33$8.00+140.24%Buy
MOVE$0.48N/AN/A

Apyx Medical Stock Forecast FAQ

Is Apyx Medical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: APYX) stock is to Strong Buy APYX stock.

Out of 1 analyst, 1 (100%) are recommending APYX as a Strong Buy, 0 (0%) are recommending APYX as a Buy, 0 (0%) are recommending APYX as a Hold, 0 (0%) are recommending APYX as a Sell, and 0 (0%) are recommending APYX as a Strong Sell.

If you're new to stock investing, here's how to buy Apyx Medical stock.

What is APYX's revenue growth forecast for 2024-2026?

(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 1.72% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Apyx Medical's revenue in 2024 is $52,349,000.On average, 1 Wall Street analysts forecast APYX's revenue for 2024 to be $1,734,274,936, with the lowest APYX revenue forecast at $1,734,274,936, and the highest APYX revenue forecast at $1,734,274,936. On average, 1 Wall Street analysts forecast APYX's revenue for 2025 to be $1,857,260,873, with the lowest APYX revenue forecast at $1,857,260,873, and the highest APYX revenue forecast at $1,857,260,873.

In 2026, APYX is forecast to generate $2,038,448,606 in revenue, with the lowest revenue forecast at $2,038,448,606 and the highest revenue forecast at $2,038,448,606.

What is APYX's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: APYX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of -0.02%.

What is APYX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year APYX price target, the average APYX price target is $5.00, with the highest APYX stock price forecast at $5.00 and the lowest APYX stock price forecast at $5.00.

The Wall Street analyst predicted that Apyx Medical's share price could reach $5.00 by Nov 10, 2024. The average Apyx Medical stock price prediction forecasts a potential upside of 237.84% from the current APYX share price of $1.48.

What is APYX's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: APYX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.